M C Kiernan
Overview
Explore the profile of M C Kiernan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perez-Siles G, Ellis M, Ashe A, Grosz B, Vucic S, Kiernan M, et al.
Front Genet
. 2022 Feb;
12:801253.
PMID: 35126465
Spinal Muscular Atrophy (SMA) is a heterogeneous group of neuromuscular diseases characterized by degeneration of anterior horn cells of the spinal cord, leading to muscular atrophy and weakness. Although the...
2.
Garcia-Montojo M, Fathi S, Norato G, Smith B, Rowe D, Kiernan M, et al.
J Neurol Sci
. 2021 Mar;
423:117358.
PMID: 33653604
Reactivation of Human Endogenous Retrovirus K (HERV-K), subtype HML-2, has been associated with pathophysiology of amyotrophic lateral sclerosis (ALS). We aimed to assess the efficacy of antiretroviral therapy in inhibiting...
3.
Dharmadasa T, Howells J, Matamala J, Simon N, Burke D, Vucic S, et al.
Eur J Neurol
. 2020 Sep;
28(1):90-97.
PMID: 32902860
Background And Purpose: In amyotrophic lateral sclerosis, studies using threshold-tracking transcranial magnetic stimulation (TMS) have identified corticomotoneuronal dysfunction as a key pathogenic mechanism. Some patients, however, display no motor response...
4.
Kandula T, Farrar M, Cohn R, Carey K, Johnston K, Kiernan M, et al.
Clin Neurophysiol
. 2020 Feb;
131(4):783-790.
PMID: 32066096
Objective: In the context of increasing numbers of childhood cancer survivors (CCS), this study aimed to enhance understanding of the biophysical basis for long term chemotherapy induced peripheral neuropathy from...
5.
Huynh W, Sharplin L, Caga J, Highton-Williamson E, Kiernan M
Eur J Neurol
. 2019 Nov;
27(4):685-691.
PMID: 31750604
Background And Purpose: Amyotrophic lateral sclerosis (ALS) is increasingly recognized as a multisystem disorder with 30%-50% of patients exhibiting cognitive impairment. The pathophysiological mechanisms of cognitive dysfunction are probably multifactorial...
6.
Borire A, Issar T, Kwai N, Visser L, Simon N, Poynten A, et al.
Diabet Med
. 2019 Jul;
37(2):343-349.
PMID: 31338857
Aims: To undertake sonographic assessment of nerve blood flow in people with Type 2 diabetes and correlate the findings with neuropathy severity scores and electrophysiological measurements. Methods: Median and tibial...
7.
Garg N, Park S, Howells J, Vucic S, Yiannikas C, Mathey E, et al.
Eur J Neurol
. 2019 Mar;
26(8):1121-1129.
PMID: 30882969
Background And Purpose: Conduction block is a pathognomonic feature of immune-mediated neuropathies. The aim of this study was to advance understanding of pathophysiology and conduction block in chronic inflammatory demyelinating...
8.
Agarwal S, Ahmed R, DMello M, Foxe D, Kaizik C, Kiernan M, et al.
Eur J Neurol
. 2018 Dec;
26(5):774-779.
PMID: 30565360
Background And Purpose: Predicting the course of behavioural variant frontotemporal dementia (bvFTD) remains a major clinical challenge. This study aimed to identify factors that predict survival and clinical progression in...
9.
Baker M, Dharmadasa T, Jaiser S, Kiernan M
Clin Neurophysiol
. 2018 May;
129(7):1455-1456.
PMID: 29754830
No abstract available.
10.
Caga J, Hsieh S, Highton-Williamson E, Zoing M, Ramsey E, Devenney E, et al.
J Neurol
. 2017 Dec;
265(1):187-193.
PMID: 29189922
Apathy is one of the most common behavioural symptoms of amyotrophic lateral sclerosis (ALS), yet there are few studies that have investigated the relationship between apathy and quality of life...